Increased monocyte MCP-1 production in acute alcoholic hepatitis

Cytokine

Volumn 11, Issue 11, 1999, Pages 875-881

  Devalaraja, Madhav N ^a   McClain, Craig J ^a,b   Barve, Shirish ^b   Vaddi, Kris ^c   Hill, Daniell B ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c GENZYME CORPORATION   (United States)

Author keywords

Alcoholic hepatitis; Alcoholic liver disease; Chemokine; Chemotactic factor; Cytokine

Indexed keywords

ACETYLCYSTEINE; BILIRUBIN; ENDOTOXIN; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS;

EID: 0032700843     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1999.0495     Document Type: Article

References (49)

1. Paronetto F. Cell mediated immunity in liver disease. Hum Pathol. 17:(1986);168-178.
2. MacSween RNM. Alcoholic liver disease: Morphological manifestations. Review by an International Group. Lancet. 1:(1981);707-711.
3. Shirahama M, Ishibashi Y, Tsuchiya S, Kurokawa Y, Okumura Y, Nino Y. Kinetics and parameters of the induction of interleukin-1 secretion by rat Kupffer cells. J Clin Lab Immunol. 27:(1988);127-132.
4. Karck U, Peters T, Decker K. The release of tumor necrosis factor by endotoxin-stimulated rat Kupffer cells is regulated by prostaglandin E2 and dexamethasone. J Hepatol. 7:(1988);352-361.
5. Chenuse W, Terebuh PD, Remick DG, Scales WE, Kunkel SL. In vivo biologic and immunohistochemical analysis of interleukin-1α,β and tumor necrosis factor during experimental endotoxemia: kinetics. Kupffer cell expression and glucocorticoid effects. Am J Pathol. 138:(1991);395-402.
6. Adachi Y, Bradford B, Gao W, Bojes H, Thurman R, Diehl AM. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology. 20:(1994);453-460.
7. McClain C, Hill D, Schmidt J. Cytokines and alcoholic liver disease. Semin Liver Dis. 13:(1993);170-182.
8. +lymphocytes. FASEB J. 8:(1994);1055-1060.
9. Leonard EJ, Yoshimura T. Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today. 11:(1990);97-101.
10. Kunkel SL, Standiford T, Kasahara K, Strieter RM. Stimulus specific induction of monocyte chemotactic protein-1 (MCP-1) gene expression. Westwick J. Chemotactic Cytokines. (1991);65-71 Plenum Press, New York.
11. Brieland JK, Flory CM, Jones ML, Miller GR, Remick DG, Warren JS, Fantone JC. Regulation of monocyte chemoattractant protein-1 gene expression and secretion in rat pulmonary alveolar macrophages by lipopolysaccharide, tumor necrosis factor-α, and interleukin-1β Am J Resp Cell Mol Biol. 12:(1995);104-109.
12. Ebnet K, Brown KD, Siebenlist UK, Simon MM, Shaw S. Borrelia burgdorferi activates nuclear factor-κB and is a potent inducer of chemokine and adhesion molecule gene expression in endothelial cells and fibroblasts. J Immunol. 158:(1997);3285-3292.
13. Sato M, Takashi M, Nagaya T, Murata Y, Ida N, Maeda K, Seo H. Antioxidants inhibit tumor necrosis factor-α mediated stimulation of interleukin-monocyte chemoattractant protein-1, and collagenase expression in cultured human synovial cells. J Rheumatol. 23:(1996);432-438.
14. Maddrey WC, Boitnott JK, Marshall S. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 75:(1978);193-199.
15. Mendenhall CL, Anderson S, Garcia-Pont P. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med. 311:(1984);1464-1470.
16. Leevy CM, Propper H, Sherlock S. Diseases of the liver and biliary tract. Standardization of nomenclature, diagnostic criteria and diagnostic methodology. 1976.
17. McClain CJ, Cohen DA. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology. 9:(1989);349-351.
18. McClain CJ, Cohen DA, Dinarello CA, Cannon JG, Shedlofsky SI, Kaplan AM. Serum interleukin-1 (IL-1) activity in alcoholic hepatitis. Life Sci. 39:(1986);1479-1485.
19. Bode C, Kugler V, Bode JC. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol. 4:(1987);8-14.
20. Bjarnason I, Ward K, Peters TJ. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet. 1:(1984);179-182.
21. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology. 13:(1991);267-276.
22. Deviere J, Content J, Denys C, Vandenbussche P, Schandene L, Wybran J, Dupont E. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology. 11:(1990);628-634.
23. Felver ME, Mezey E, McGuire M, Mitchell MC, Herlong HF, Veech GA, Veech RL. Plasma tumor necrosis factor α predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res. 14:(1990);255-259.
24. Bird GLA, Sheron N, Goka J, Alexander GJ, Williams RS. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Int Med. 112:(1990);917-920.
25. Sheron N, Bird G, Koskinas J, Portmann B, Ceska M, Lindley I, Williams R. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology. 18:(1993);41-46.
26. Hill DB, Marsano LS, McClain CJ. Increased plasma interleukin-8 concentrations in alcoholic hepatitis. Hepatology. 18:(1993);576-580.
27. Maltby J, Wright S, Bird G, Sheron N. Chemokine levels in human liver homogenates: Associations between GRO alpha and histopathological evidence of alcoholic hepatitis. Hepatology. 24:(1996);1156-1160.
28. Czaja MJ, Geerts A, Xi J, Schmiedeberg P, Ju Y. Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease. J Leukoc Biol. 55:(1994);120-126.
29. Brun P, Afford SC, Fear J, Burra P, Hubscher SG, Adams DH. Increased expression of β chemokines in alcoholic liver disease. Hepatology. 22:(1995);364a.
30. Honchel R, Ray M, Marsano L. Tumor necrosis factor in alcohol enhanced endotoxin liver injury. Alcohol Clin Exp Res. 16:(1992);665-669.
31. Hansen J, Cherwitz DL, Allen JI. The role of tumor necrosis factor-α in acute endotoxin-induced hepatotoxicity in ethanol-fed rats. Hepatology. 20:(1994);461-474.
32. Nanji AA, Zhao S, Sadradeh SM, Waxman DJ. Use of reverse transcription-polymerase chain reaction to evaluate in vivo cytokine gene expression in rats fed ethanol for long periods. Hepatology. 19:(1994);1483-1487.
33. Hill DB, Schmidt J, Shedlofsky SI, Cohen DA, McClain CJ. In vitro tumor necrosis factor cytotoxicity in HEP G2 liver cells. Hepatology. 21:(1995);1114-1119.
34. Shiratori Y, Tanaka M, Hai K, Kawase T, Shina S, Sugimoto T. Role of endotoxin-responsive macrophages in hepatic injury. Hepatology. 11:(1990);183-192.
35. Lieber CS. Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases. Adv in Pharm. 38:(1997);601-628.
36. Situnayake RD, Crump BJ, Thurnham DI, Davies JA, Gearty J, Davis M. Lipid peroxidation and hepatic antioxidants in alcoholic liver disease. Gut. 31:(1990);1311-1317.
37. Thanos D, Maniatis T. NF-κB: A lesson in family values. Cell. 80:(1995);529-532.
38. Mihm S, Galter D, Droge W. Modulation of transcription factor NFκB activity in intracellular glutathione levels and by variations of the extra cellular cysteine supply. FASEB J. 9:(1995);246-252.
39. Tran-Thi T-A, Decker K, Baeuerle PA. Differential activation of transcription factors NF-κB and AP-1 in rat liver macrophages. Hepatology. 22:(1995);613-619.
40. Hill D, Shedlofsky S, McClain C, Diehl AE, Tsukamoto H. Cytokines and liver disease. Remick DG, Friedland JS. Cytokines in Health and Disease. (1997);401-425 Marcel Dekker, Inc. New York.
41. Yamaguchi Y, Matsumura F, Takeya M, Ichiguchi O, Kuratsu JI, Horiuchi T, Akizuki E, Matsuda T, Okabe K, Ohshiro H, Liang J, Mori K, Yamada S, Takahashi K, Ogawa M. Monocyte chemoattractant protein-1 enhances expression of intercellular adhesion molecule-1 following ischemia-reperfusion of the liver in rats. Hepatology. 27:(1998);727-734.
42. Marra F, Valente AJ, Pinzani M, Abboud HE. Cultured human fat-storing cells produce monocyte chemotactic protein-1 regulation by proinflammatory cytokines. J Clin Invest. 92:(1993);1674-1680.
43. Gu L, Rutledge B, Fiorillo J, Ernst C, Grewal I, Flavell R, Gladue R, Rollins B. In vivo properties of monocyte chemoattractant protein-1. J Leuk Biol. 62:(1997);577-580.
44. Darban H, Crawford GB, Watson RR. Alcohol and the human immune system. Watson RR. Alcohol, Drugs of Abuse and Immunomodulation. (1993);5-9 Pergamon Press, New York.
45. Snyder N, Bessoff J, Dwyer JM. Depressed delayed cutaneous hypersensitivity in alcoholic hepatitis. Am J Dig Dis. 23:(1978);353-358.
46. Berger SR, Helms RA, Bull DM. Hypergammaglobulinemia: increased rates of Ig synthesis by circulating lymphoid cells. Dig Dis Sci. 24:(1979);741-745.
47. Karpus WJ, Kennedy KJ. MIP-1α and MCP-1 differentially regulate acute and releasing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J Leuk Biol. 62:(1997);681-687.
48. Lukacs K, Cohen DA, Kaplan AM. HLA-Dr-unrestricted accessory cell function in human neutrophils. Clin Immunol Immunopathol. 38:(1986);344-349.
49. 2-isoprostane excretion in alcoholic liver disease. Free Radical Biology & Medicine. 26:(1999);656-660.